SPWM
Straight Path Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $838K | Hold |
50,000
| – | – | 0.28% | 34 |
|
|
2025
Q1 | $769K | Sell |
50,000
-16,000
| -24% | -$246K | 0.31% | 33 |
|
|
2024
Q4 | $1.45M | Hold |
66,000
| – | – | 0.58% | 24 |
|
|
2024
Q3 | $1.19M | Hold |
66,000
| – | – | 0.51% | 24 |
|
|
2024
Q2 | $1.07M | Hold |
66,000
| – | – | 0.55% | 24 |
|
|
2024
Q1 | $931K | Hold |
66,000
| – | – | 0.52% | 27 |
|
|
2023
Q4 | $689K | Hold |
66,000
| – | – | 0.4% | 31 |
|
|
2023
Q3 | $673K | Hold |
66,000
| – | – | 0.46% | 30 |
|
|
2023
Q2 | $497K | Sell |
66,000
-25,000
| -27% | -$188K | 0.34% | 39 |
|
|
2023
Q1 | $805K | Hold |
91,000
| – | – | 0.64% | 23 |
|
|
2022
Q4 | $830K | Buy |
91,000
+19,600
| +27% | +$179K | 0.8% | 22 |
|
|
2022
Q3 | $576K | Buy |
71,400
+5,400
| +8% | +$43.6K | 0.52% | 33 |
|
|
2022
Q2 | $496K | Hold |
66,000
| – | – | 0.49% | 34 |
|
|
2022
Q1 | $620K | Buy |
66,000
+10,000
| +18% | +$93.9K | 0.53% | 30 |
|
|
2021
Q4 | $449K | Buy |
+56,000
| New | +$449K | 0.39% | 38 |
|